Concerns about anaesthesia-related neurological injury in young children have been increasing among parents, health-care providers, and regulatory organisations. These concerns were first prompted by animal studies that showed accelerated apoptosis and neuronal death after exposure to general anaesthetic drugs. Most commonly used general anaesthetic drugs have since been found to cause pervasive adverse neurological effects in vitro and in immature animals, including non-human primates. This issue gained widespread prominence in 2017, when the US Food and Drug Administration issued a safety communication stating that the use of general anaesthetic drugs “for lengthy periods of time or over multiple surgeries or procedures may negatively affect brain development in children younger than 3 years”. Subsequently, warnings were added to the labels for these medicines.
Recent Posts
- SmartTots and the Power of Scientific Public–Private Partnerships with the US Food and Drug Administration
- Effects of Dexmedetomidine-Remifentanil on Neurodevelopment of Children after Inhalation Anesthesia: A Randomized Clinical Trial
- A Scoping Review of the Mechanisms Underlying Developmental Anesthetic Neurotoxicity
- Anesthesia-induced Developmental Neurotoxicity in Pediatric Population
- Experiencing Anesthesia and Surgery Early in Life Impairs Cognitive and Behavioral Development